Safety and efficacy of riboflavin-assisted collagen cross-linking of cornea in progressive keratoconus patients: A prospective study in North East India

CONCLUSION: Riboflavin-assisted C3R treatment showed promising efficacy in the treatment of PK patients in our population. As the collagen turnover rate of cornea is 2–3 years and the progression of PK is highly variable, we need long-term studies to evaluate the efficacy of C3R over time, requirement of repeat therapy, and safety of repeat cross-linking.

Source: Indian Journal of Pharmacology - July 8, 2019 Category: Drugs & Pharmacology Authors: Anusuya Bhattacharyya Phulen Sarma Kalyan Das Balmukund Agarwal Jnanankar Medhi Shyam Sundar Das Mohapatra Source Type: research